Therapeutic effect of Chinese prescription Kangen-karyu in patients with diabetic nephropathy-Reference-Cited by-同舟云学术

Therapeutic effect of Chinese prescription Kangen-karyu in patients with diabetic nephropathy

Published:2020-04-30 Issue:2 Volume:14 Page:84-88
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Park Chan Hum¹,Hiratani Kazuyuki²,Natazuka Toshiki²,Yokozawa Takako³

Affiliation:

1. Department of Medicinal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, Republic of Korea.

2. Shinseikai Toyama Hospital, Toyama, Japan.

3. Graduate School of Science and Engineering for Research, University of Toyama, Toyama, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01013/_pdf

Reference32 articles.

1. 1. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991-2005). Diabetes Care. 2007; 30:3070-3076.

2. 2. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet. 2015; 385:1975-1982.

3. 3. Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial. Lancet. 2008; 372:547-553.

4. 4. Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G, ASCEND Study Group. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol. 2010; 21:527-535.

5. 5. Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013; 369:1892-1903.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Network Pharmacology Approach to Understand the Action Mechanisms of the TangShenKangPing Decoction for Diabetic Nephropathy Treatment;Integrative Medicine in Nephrology and Andrology;2023-09-13

2. Clinical study on prescription used for invigorating spleen, reinforcing kidney and warming yang combined with calcium dobesilate in treatment of senile diabetic nephropathy;Biotechnology and Genetic Engineering Reviews;2023-04-04

3. Poly-γ-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy;Journal of Drug Targeting;2022-07-31

4. OVEREXPRESSION OF SNON INHIBITS HIGH-GLUCOSE-INDUCED RENAL TUBULAR EPITHELIAL MESENCHYMAL TRANSITION BY REGULATING ARKADIA EXPRESSION;ACTA MEDICA MEDITERR;2022

5. Dendrobium mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway;Molecular Medicine Reports;2021-06-17